Booth L, Roberts J, Poklepovic A, Gordon S, Dent P. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide. Oncotarget. 2017;8:1449-1468 pubmed 出版商

Tavallai M, Booth L, Roberts J, Poklepovic A, Dent P. Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic. Front Oncol. 2016;6:142 pubmed 出版商

Booth L, Shuch B, Albers T, Roberts J, Tavallai M, Proniuk S, et al. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Oncotarget. 2016;7:12975-96 pubmed 出版商

Dent P, Booth L, Roberts J, Poklepovic A, Cridebring D, Reiman E. Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43. Aging (Albany NY). 2021;13:17097-17117 pubmed 出版商

Sun J, Wei S, Zhang Y, Li J. Protective Effects of Astragalus Polysaccharide on Sepsis-Induced Acute Kidney Injury. Anal Cell Pathol (Amst). 2021;2021:7178253 pubmed 出版商

Dicks N, Bohrer R, Gutierrez K, Michalak M, Agellon L, Bordignon V. Relief of endoplasmic reticulum stress enhances DNA damage repair and improves development of pre-implantation embryos. PLoS ONE. 2017;12:e0187717 pubmed 出版商

Booth L, Roberts J, Sander C, Lee J, Kirkwood J, Poklepovic A, et al. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget. 2017;8:16367-16386 pubmed 出版商

Booth L, Roberts J, Poklepovic A, Dent P. PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]. Oncotarget. 2017;8:13464-13475 pubmed 出版商

Booth L, Albers T, Roberts J, Tavallai M, Poklepovic A, Lebedyeva I, et al. Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo. Oncotarget. 2016;7:40398-40417 pubmed 出版商

Booth L, Roberts J, Tavallai M, Chuckalovcak J, Stringer D, Koromilas A, et al. [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling. Oncotarget. 2016;7:23608-32 pubmed 出版商